https://humabiologics.com/wp-content/uploads/2022/11/BGHL-5mg.png19201920Madeline Damascohttps://humabiologics.com/wp-content/uploads/2024/06/Logo.pngMadeline Damasco2022-08-26 15:10:002023-07-31 12:40:28Human gelatin-based composite hydrogels for osteochondral tissue engineering and their adaptation into bioinks for extrusion, inkjet, and digital light processing bioprinting
https://humabiologics.com/wp-content/uploads/2022/11/SCL-100mg.png19201920Madeline Damascohttps://humabiologics.com/wp-content/uploads/2024/06/Logo.pngMadeline Damasco2022-05-09 20:57:002023-07-31 12:13:48Native human collagen type I provides a viable physiologically relevant alternative to xenogeneic sources for tissue engineering applications: A comparative in vitro and in vivo study.
https://humabiologics.com/wp-content/uploads/2022/11/SCL-100mg-1.png19201920Madeline Damascohttps://humabiologics.com/wp-content/uploads/2024/06/Logo.pngMadeline Damasco2022-04-21 20:29:312023-07-31 12:35:443D bioprinting of an implantable xeno-free vascularized human skin graft
https://humabiologics.com/wp-content/uploads/2024/11/patent-bg.jpg8801920vishalhttps://humabiologics.com/wp-content/uploads/2024/06/Logo.pngvishal2024-11-18 11:02:252024-11-18 11:26:21Humabiologics Secures Two Patents for Breakthrough Human Biomaterial Production
https://humabiologics.com/wp-content/uploads/2024/11/patent-bg.jpg8801920Liana Sotohttps://humabiologics.com/wp-content/uploads/2024/06/Logo.pngLiana Soto2024-08-20 11:24:592024-12-09 11:39:143D HEALS Interview with Dr. Mohammad Albanna: Humabiologics